BR112012001229A2 - formulação farmacêutica aquosa, uso da formulação farmacêutica aquosa - Google Patents

formulação farmacêutica aquosa, uso da formulação farmacêutica aquosa

Info

Publication number
BR112012001229A2
BR112012001229A2 BR112012001229A BR112012001229A BR112012001229A2 BR 112012001229 A2 BR112012001229 A2 BR 112012001229A2 BR 112012001229 A BR112012001229 A BR 112012001229A BR 112012001229 A BR112012001229 A BR 112012001229A BR 112012001229 A2 BR112012001229 A2 BR 112012001229A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical formulation
aqueous pharmaceutical
aqueous
formulation
pharmaceutical
Prior art date
Application number
BR112012001229A
Other languages
English (en)
Inventor
Michael Boll
Original Assignee
Braun Melsungen Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Braun Melsungen Ag filed Critical Braun Melsungen Ag
Publication of BR112012001229A2 publication Critical patent/BR112012001229A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
BR112012001229A 2009-07-20 2010-07-15 formulação farmacêutica aquosa, uso da formulação farmacêutica aquosa BR112012001229A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102009034132A DE102009034132A1 (de) 2009-07-20 2009-07-20 Plasmaadaptierte und balancierte Gelatinelösung
PCT/EP2010/060210 WO2011009797A2 (de) 2009-07-20 2010-07-15 Plasmaadaptierte und balancierte gelatinelösung

Publications (1)

Publication Number Publication Date
BR112012001229A2 true BR112012001229A2 (pt) 2016-03-01

Family

ID=43334706

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012001229A BR112012001229A2 (pt) 2009-07-20 2010-07-15 formulação farmacêutica aquosa, uso da formulação farmacêutica aquosa

Country Status (9)

Country Link
EP (1) EP2456446A2 (pt)
KR (1) KR20120046160A (pt)
CN (1) CN102470147A (pt)
BR (1) BR112012001229A2 (pt)
DE (2) DE102009034132A1 (pt)
IN (1) IN2012DN00419A (pt)
MX (1) MX2012000957A (pt)
RU (1) RU2012105925A (pt)
WO (1) WO2011009797A2 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2651717B1 (es) * 2016-07-26 2018-11-16 Lara OLLER DUQUE Solución acuosa cristaloide isotónica

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA702706B (en) * 1969-04-28 1971-12-29 Knox Gelatine Inc Blood plasma substitute
EP0223906A3 (en) * 1982-10-29 1989-02-01 Synthetic Blood Corporation Gelatin based synthetic whole blood and a process for preparing the same
EP1238675A1 (en) 2001-03-06 2002-09-11 Fuji Photo Film B.V. Recombinant gelatin-like proteins for use as plasma expanders

Also Published As

Publication number Publication date
KR20120046160A (ko) 2012-05-09
RU2012105925A (ru) 2013-08-27
WO2011009797A2 (de) 2011-01-27
CN102470147A (zh) 2012-05-23
DE202010018349U1 (de) 2015-10-28
WO2011009797A3 (de) 2011-08-25
EP2456446A2 (de) 2012-05-30
DE102009034132A1 (de) 2011-01-27
MX2012000957A (es) 2012-03-06
IN2012DN00419A (pt) 2015-05-15

Similar Documents

Publication Publication Date Title
BR112012013148A2 (pt) formulação farmacêutica e uso
BRPI1008793A2 (pt) composto, uso de um composto, e, composição farmacêutica
BRPI1016219A2 (pt) composto, composição farmacêutica, e, uso de um composto
SMT201400069B (it) Formulazione farmaceutica
BRPI1007018A2 (pt) composto, composição farmacêutica, e , uso de um composto.
BR112013008259A2 (pt) composto, composição farmacêutica, e, uso de um composto
BR112012003842A2 (pt) composição farmacêutica, método de formulação e uso da mesma
BRPI1008906A2 (pt) composto, composição farmacêutica, e, uso de um composto.
BR112013015397A2 (pt) composto, composição farmacêutica, e, uso de um composto
BR112013016772A2 (pt) composto, uso do composto, composição farmacêutica, oligonucleotídeo e conjugado
BR112012002331A2 (pt) composição antiviral, composição farmacêutica e uso de quantidade efetiva de composição farmacêutica
BRPI1009372A2 (pt) compostos, composição farmacêutica e respectivos usos
DK3045164T3 (da) Vandige farmaceutiske sammensætninger, der indeholder borat-polyol-komplekser
BR112012031226A2 (pt) composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica
BR112013011448A2 (pt) composto, composição farnmacêutica, e, uso do composto
BRPI0921654A2 (pt) formulação farmacêutica
DK2391349T3 (da) Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater
BRPI1007186A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI1009757A2 (pt) composto, composição farmacêutica, e , uso de um composto.
BRPI0907228A2 (pt) Compostos de tienopiridazina, suas preparações, composições farmacêuticas e usos
BRPI0922653A2 (pt) preparação farmacêutica
BR112013014189A8 (pt) composição farmacêutica, uso de um agente de potencialização e uso de uma composição
DK2193795T3 (da) Latanoprostholdig vandig farmaceutisk sammensætning
BR112012031967A2 (pt) composto, uso de um composto, combinação de um composto e composição farmacêutica
BRPI1009067A2 (pt) derivados de nitrila, seu uso farmaceutico e composições

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application fees: application dismissed [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2470 DE 08-05-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]